SAVE THE DATE: Second Annual JeffX Global Health Conference

Save the date for the Second Annual JeffX Global Health Conference: Planetary Health!

WHEN: Friday, January 24, 2020 from 3:00 – 8:30 pm
WHERE: Thomas Jefferson University, Philadelphia, PA

KEYNOTE: Dr. Jo Ivey Boufford, MD, President, International Society for Urban Health; Clinical Professor, Global Public Health, New York University; Clinical Professor, Pediatrics, NYU School of Medicine.

Lecture Series @ Osher Lifelong Learning Institute, Fall 2019

 

 

Fall 2019 Semester begins Tuesday, September 3rd!
Class time: 9:00 – 10:15 am
Register Online: http://www.olli.udel.edu/wilmington/registration/


September 3, 2019:
The PreDiabetic Discussion

September 10, 2019: Biosafety

September 17, 2019: Athersclerosis

September 24, 2019: Bone Health

October 1, 2019: Trends in Healthcare

October 8, 2019: Obstructive Sleep Apnea – Contemporary Surgical Management

October 15, 2019: Measles Update

October 22, 2019: Socioeconomic Variation and Cancer

October 29: Spleen 101

November 5: Hypertension / Kidney

November 12: About the Medical Society of Delaware

November 19: Respiratory Therapy

November 26: Thanksgiving Break, No Class

December 3: Neuro-Movement Disorder Case Studies

CDC Public Health Grand Rounds

PFAs and Protecting Your Health

Tuesday, November 19, 2019
1:00 pm ET
Watch in person (Global Communications Center, Building 19), or live via webcast.

 

Human exposure to PFAS (per- and polyfluoroalkyl substances) is a growing public health concern. PFAS are a large group of human-made chemicals that have been used in industry and consumer products worldwide since the 1950s. These chemicals are in food packaging and many other household products, and have been found in the air, soil, and water.

 

Previous Grand Rounds

Learn More

Innovative Discoveries Series

Implementing evidence-based pediatric psychosocial services: Bringing research and practice together

Dr. Price will provide a brief overview of examples of evidence-based pediatric psychology practices and offer data regarding the current reach of these services. She will introduce the field of implementation science, offering theoretical and methodological fundamentals of this new and growing field. Dr. Price will then apply these principles of implementation science to pediatric psychology, describing her stepped model of conducting this line of research and reviewing preliminary data from two pediatric populations. Dr. Price will enumerate areas for future research.

 

Presented By:

Julia Price, PhD

Research Scientist and Pediatric Psychologist, Nemours Children’s Health System
Assistant Professor, Pediatrics, Thomas Jefferson University

Free!  Lunch will be served!

This activity has been approved for AMA PRA Category 1 Credit.

REGISTER ONLINE TODAY!

Friday, December 13, 2019
Noon to 1 p.m.
In-person: Christiana Hospital, Room 1100
Online: Watch live at https://bluejeans.com/361095905
Or join meeting ID 361095905 on the BlueJeans app on your smartphone or tablet

This activity has been approved for AMA PRA Category 1 Credit.

Upcoming Lectures:

January 24, 2020: Saira Khan, University of Delaware

Statement on Vaccines

Vaccines Continue to be Tested and Proven Safe

American Academy of Pediatrics. (2017). American Academy of Pediatrics Emphasizes Safety and Importance of Vaccines. Retrieved from https://www.aap.org/en-us/about-the-aap/aap-press-room/Pages/American-Academy-of-Pediatrics-Emphasizes-Safety-and-Importance-of-Vaccines.aspx

Centers for Disease Control and Prevention. (2016). Infant Immunizations FAQs. Retrieved from https://www.cdc.gov/vaccines/parents/parent-questions.html

Institute of Medicine. (2004). Immunization Safety Review: Vaccines and Autism. Retrieved from https://www.nap.edu/catalog/10997/immunization-safety-review-vaccines-and-autism

U.S. Food and Drug Administration. (2015).  Thimerosal in Vaccines: Questions and Answers. Retrieved from http://www.fda.gov/BiologicsBloodVaccines/Vaccines/QuestionsaboutVaccines/UCM070430#q5

In light of recent claims by politicians or appointees that vaccines are linked to autism, or are unsafe when administered according to the recommended schedule, or contain dangerous products like Thimerosal, the public health community and the Delaware Academy of Medicine/Delaware Public Health Association continue to come down on the side of science.

The Food and Drug Administration (FDA) Center for Biologics Evaluation and Research is responsible for regulating vaccines in the United States.  Before a vaccine can be licensed for public use, it must be tested for safety in the laboratory, in animals, and in human clinical trials.  Human clinical trials include looking for common adverse events in a few participants (phase 1), several hundred volunteers looking for local reactions and general side effects like fever (phase 2), and establishing the effectiveness of the vaccine and determining less common side effects with thousands of participants (phase 3).  If a vaccine is to be given at the same time as another vaccine, the two vaccines are tested together (FDA, 2015).  If a dangerous effect is found, that vaccine is not licensed for public use.

Vaccines are continuously monitored following licensure by the Vaccine Adverse Event Reporting System (VAERS), which is run by both the FDA and the Centers for Disease Control (CDC).  The VAERS is a national system that collects all reports of adverse events following vaccination.  Phase 4 clinical studies are also conducted to further evaluate the new vaccine, and population based studies are conducted through the use of databases like the Vaccine Safety Datalink (VSD) for the lifetime of the use of the vaccine (FDA, 2015).

The Institute of Medicine (IOM) Immunization Safety Review Committee “favors rejection of a causal relationship between thimerosal-containing vaccines and autism” (IOM, 2004).  Despite this finding, “all vaccines routinely recommended for children 6 years of age or younger and marketed in the U.S. contain no thimerosal or only trace amounts” (FDA, 2015).

“Infants and young children who follow immunization schedules that spread out shots – or leave out shots – are at risk of developing diseases during the time that shots are delayed” (CDC, 2016). Vaccines “keep communities healthy, and protect some of the most vulnerable in our society” (American Academy of Pediatrics, 2017).  The Delaware Academy of Medicine will continue to advocate for vaccines and vaccine use in the state of Delaware and the United States.